Drug-induced liver injury (DILI) is a widespread and harmful disease closely linked to
mitochondrial and endoplasmic reticulum stress (ERS). Globally, severe drug-induced …

Venous thromboembolism (VTE) is a common complication in patients with cancer and
portends a poor prognosis. Our understanding of the underlying pathophysiology of VTE in …

Chemotherapy-induced thrombocytopenia (CIT) is a common complication of antineoplastic
therapy, resulting in antineoplastic therapy dose reductions, treatment delays, treatment …

Natural anticoagulant drugs can be obtained from plants, rich in secondary bioactive
metabolites which, in addition to being effective antioxidants, also possess anticoagulant …

Background Antithrombotics are frequently prescribed for patients with a limited life
expectancy. In the last phase of life, when treatment is primarily focused on optimizing …

Venous thromboembolism (VTE) is common in patients with cancer and is an important
contributor to morbidity and mortality in these patients. Early thromboprophylaxis initiated …

Simple Summary Direct-acting oral anticoagulants are becoming popular therapeutic option
in patients with cancer. We investigated the available literature in order to try to sum up the …

Background Cancer associated venous thromboembolism (VTE) results in significant
morbidity and mortality. Low molecular weight heparin (LMWH) has been standard of care …

Cancer patients generally has a high risk of thrombotic diseases. However, anticoagulant
therapy always aggravates bleeding risks. Rivaroxaban is one of the most widely used direct …

Background To evaluate the efficacy and safety of different direct oral anticoagulants
(DOACs) compared with low molecular weight heparins (LMWHs) in the treatment of venous …